Beneficial Effects of Rosmarinic Acid In Vitro and In Vivo Models of Epileptiform Activity Induced by Pilocarpine
Authors:
- Bruna NeubergerBNBruna Neuberger
- Fernanda Kulinski MelloFMFernanda Kulinski Mello
- Michele Pereira MallmannMMMichele Pereira Mallmann
- Karine Gabriela da Costa SobralKSKarine Gabriela da Costa Sobral
- Michele Rechia FigheraMFMichele Rechia Fighera
- Luiz Fernando Freire RoyesLRLuiz Fernando Freire Royes
- Ana Flávia FurianAFAna Flávia Furian
- Tuane Bazanella SampaioTSTuane Bazanella Sampaio
- Mauro Schneider OliveiraMOMauro Schneider Oliveira
Open Access
- 8 February 2023
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 13 (2) , 289
Abstract
Epilepsy is characterized by a predisposition to generate recurrent and spontaneous seizures; it affects millions of people worldwide. Status epilepticus (SE) is a severe type of seizure. In this context, screening potential treatments is very important. In the present study, we evaluated the beneficial effects of rosmarinic acid (RA) in pilocarpine-induced in vitro and in vivo models of epileptiform activity. Using an in vitro model in combined entorhinal cortex–hippocampal from Wistar rats we evaluated the effects of RA (10 µg/mL) on the lactate release and a glucose fluorescent analogue, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NDBG), after incubation in high potassium aCSF supplemented or not with pilocarpine. In the in vivo model, SE was induced in male C57BL/6 mice by pilocarpine. At 1, 24, and 48 h after the end of SE mice were treated with RA (30 mg/kg/v.o.). We evaluated the neuromotor impairment by neuroscore tests and protein carbonyl levels in the cerebral cortex. In both in vitro models, RA was able to decrease the stimulated lactate release, while no effect on 2-NBDG uptake was found. RA has beneficial effects in models of epileptiform activity in vivo and in vitro. We found that RA treatment attenuated SE-induced neuromotor impairment at the 48 h timepoint. Moreover, post-SE treatment with RA decreased levels of protein carbonyls in the cerebral cortex of mice when compared to their vehicle-treated counterparts. Importantly, RA was effective in a model of SE which is relevant for the human condition. The present data add to the literature on the biological effects of RA, which could be a good candidate for add-on therapy in epilepsy.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (#304708/2015-1, 308011/2019-8, 001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES) (#304708/2015-1, 308011/2019-8, 001)
This publication has 39 references indexed in Scilit:
- Quantitation of protein carbonylation by dot blotAnalytical Biochemistry, 2012
- In vivo imaging of epileptic activity using 2-NBDG, a fluorescent deoxyglucose analogJournal of Neuroscience Methods, 2012
- Hormetins, antioxidants and prooxidants: defining quercetin-, caffeic acid- and rosmarinic acid-mediated life extension in C. elegansBiogerontology, 2011
- Effect of Rosmarinic and Caffeic Acids on Inflammatory and Nociception Process in RatsISRN Pharmacology, 2011
- The role of inflammation in epilepsyNature Reviews Neurology, 2010
- FLUORODEOXYGLUCOSE–POSITRON EMISSION TOMOGRAPHIC IMAGING FOR THE DIAGNOSIS OF MESIAL TEMPORAL LOBE EPILEPSYNeurosurgery, 2008
- Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in miceExperimental Neurology, 2007
- In Vivo and In Vitro Effects of Pilocarpine: Relevance to IctogenesisEpilepsia, 2007
- Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe EpilepsyJournal of Neuroscience, 2006
- BCL-2 Overexpression Attenuates Cortical Cell Loss after Traumatic Brain Injury in Transgenic MiceJournal of Cerebral Blood Flow & Metabolism, 1998